Why is Saroja Pharma In falling/rising?

As of 03-Sep, Saroja Pharma Industries India Ltd is experiencing a price increase, currently at 49.50, reflecting a rise of 2.0 or 4.21%. The stock has shown strong performance today, outperforming its sector by 2.97%. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. However, there has been a notable decline in investor participation, with delivery volume dropping by 66.67% compared to the 5-day average. In terms of returns, the stock has gained 1.85% over the past week and an impressive 38.27% over the past month, contrasting with the Sensex, which has seen minimal movement. In the broader market context, while Saroja Pharma has outperformed the Sensex in the short term, it has underperformed year-to-date with a decline of 17.50% compared to the Sensex's gain of 4.53%. This suggests that despite recent gains, the stock has faced challenges over a longer period. The significant increase in the stock price today may be attributed to short-term trading dynamics rather than a fundamental shift in the company's performance, as indicated by the falling investor participation.